Bruker Corporation
BRKR
$45.69
$0.711.58%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.46B | 3.44B | 3.44B | 3.44B | 3.45B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.46B | 3.44B | 3.44B | 3.44B | 3.45B |
| Cost of Revenue | 1.82B | 1.79B | 1.76B | 1.76B | 1.73B |
| Gross Profit | 1.64B | 1.64B | 1.67B | 1.69B | 1.72B |
| SG&A Expenses | 960.30M | 944.10M | 945.90M | 933.30M | 923.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 26.10M | 28.50M | -29.80M | 11.70M | 9.90M |
| Total Operating Expenses | 3.20B | 3.16B | 3.08B | 3.10B | 3.05B |
| Operating Income | 255.50M | 274.60M | 358.10M | 342.00M | 395.00M |
| Income Before Tax | 13.70M | 21.00M | 8.60M | 136.30M | 158.90M |
| Income Tax Expenses | 23.10M | 29.30M | 32.20M | 61.10M | 80.30M |
| Earnings from Continuing Operations | -9.40 | -8.30 | -23.60 | 75.20 | 78.60 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -2.20M | -300.00K | 2.70M | 4.40M | 1.00M |
| Net Income | -11.60M | -8.60M | -20.90M | 79.60M | 79.60M |
| EBIT | 255.50M | 274.60M | 358.10M | 342.00M | 395.00M |
| EBITDA | 483.70M | 494.90M | 573.20M | 552.40M | 594.50M |
| EPS Basic | -0.24 | -0.15 | -0.16 | 0.53 | 0.53 |
| Normalized Basic EPS | 0.92 | 1.00 | 1.37 | 1.30 | 1.53 |
| EPS Diluted | -0.24 | -0.15 | -0.16 | 0.52 | 0.52 |
| Normalized Diluted EPS | 0.91 | 1.00 | 1.36 | 1.29 | 1.52 |
| Average Basic Shares Outstanding | 607.60M | 607.00M | 606.60M | 606.30M | 602.10M |
| Average Diluted Shares Outstanding | 608.70M | 607.90M | 607.40M | 607.60M | 603.90M |
| Dividend Per Share | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 |
| Payout Ratio | -377.59% | -382.56% | -109.57% | 38.32% | 38.44% |